BRD2 and neoplasm: Our goals were (i) to delineate HP-associated transcriptional programs in each tissue and (ii) to assess whether these programs align with two complementary axes—steroid-hormone/lipid–drug-metabolism in NAT versus tight-junction/ECM remodeling in tumor.